SKI Market

A+| A| A-|

Indian Indices

Sensex

73,134.32 1,186.77
( 1.65%)

Global Indices

Nasdaq

46,363.90 1,126.75
(2.49%)

Dow Jones

6,550.24 185.52
(2.91%)

Hang Seng

53,589.67 2,525.95
(4.95%)

Nikkei 225

10,364.79 188.34
(1.85%)

Forex

USD-INR

94.31 -0.22
(-0.23%)

EUR-INR

108.30 -0.48
(-0.44%)

GBP-INR

124.69 -0.63
(-0.50%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

61.71

6818.96

EPS(TTM)

Face Value()

Div & Yield %

5.65

0.14

Back

Ishita Drugs & Industries standalone net profit declines 26.32% in the September 2025 quarter

Nov 12,2025

Net profit of Ishita Drugs & Industries declined 26.32% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 6.12% to Rs 3.07 crore in the quarter ended September 2025 as against Rs 3.27 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3.07	3.27	-6
OPM %	5.86	7.03	-
PBDT	0.25	0.28	-11
PBT	0.22	0.25	-12
NP	0.14	0.19	-26

73,134.32 1,186.77 ( 1.65%)

46,363.90 1,126.75 (2.49%)

6,550.24 185.52 (2.91%)

53,589.67 2,525.95 (4.95%)

10,364.79 188.34 (1.85%)

94.31 -0.22 (-0.23%)

108.30 -0.48 (-0.44%)

124.69 -0.63 (-0.50%)

0.59 0.00 (0.19%)